Anouve is developing a blood based
Anouve is developing a blood based
gastric cancer screening method
gastric cancer screening method
Samples collected from clinical trials will be used to determine the performance characteristics of the test.
Blood tests will be part of our gastric cancer screening portfolio to cover the 900 million people in China who need to be screened for gastric cancer.
